Published in J Pathol on December 01, 2005
ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta (2012) 1.58
Gdnf signaling pathways within the mammalian spermatogonial stem cell niche. Mol Cell Endocrinol (2008) 1.32
Genetic control of estrogen-regulated transcriptional and cellular responses in mouse uterus. FASEB J (2013) 0.85
The role of Pea3 group transcription factors in esophageal squamous cell carcinoma. Am J Pathol (2011) 0.81
Deregulation of RAD21 and RUNX1 expression in endometrial cancer. Oncol Lett (2012) 0.80
Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion. Clin Exp Metastasis (2015) 0.78
The role of genetics in estrogen responses: a critical piece of an intricate puzzle. FASEB J (2014) 0.78
ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression. Cancer Biol Ther (2014) 0.77
An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer. Cell Rep (2016) 0.75
Genetic control of ductal morphology, estrogen-induced ductal growth, and gene expression in female mouse mammary gland. Endocrinology (2014) 0.75
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol (2011) 3.66
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood (2005) 2.90
APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology (2006) 2.25
Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts. Cardiovasc Res (2002) 1.76
Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy. BJU Int (2008) 1.64
Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer. Ann Surg Oncol (2010) 1.40
[Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ]. Cir Esp (2009) 1.39
Key contribution of CPEB4-mediated translational control to cancer progression. Nat Med (2011) 1.37
Platelet proteomics in transfusion medicine: a reality with a challenging but promising future. Blood Transfus (2012) 1.24
A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics (2006) 1.17
PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol (2005) 1.17
Snail1 protein in the stroma as a new putative prognosis marker for colon tumours. PLoS One (2009) 1.16
Failure to maintain a suppressed level of serum testosterone during long-acting depot luteinizing hormone-releasing hormone agonist therapy in patients with advanced prostate cancer. Urol Int (2006) 1.16
Platelet proteomics: state of the art and future perspective. Methods Mol Biol (2012) 1.13
Management of patients with diabetes through information technology: tools for monitoring and control of the patients' metabolic behavior. Diabetes Technol Ther (2004) 1.11
Extraperitoneal laparoscopic approach for diagnosis and treatment of aortic lymph node recurrence in gynecologic malignancy. J Minim Invasive Gynecol (2010) 1.09
The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol (2012) 1.07
Update on novel therapeutic agents for cervical cancer. Gynecol Oncol (2008) 1.06
Vulvar angiomyxoma, aggressive angiomyxoma, and angiomyofibroblastoma: an immunohistochemical and ultrastructural study. Ultrastruct Pathol (2006) 1.05
The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer (2006) 1.05
Occupational exposure to hepatitis E virus (HEV) in swine workers. Am J Trop Med Hyg (2008) 1.03
Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation. EMBO J (2005) 1.02
Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys (2006) 1.02
Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease. Mol Cell Endocrinol (2011) 1.01
Molecular markers of endometrial carcinoma detected in uterine aspirates. Int J Cancer (2011) 1.00
Notch pathway inhibition significantly reduces rhabdomyosarcoma invasiveness and mobility in vitro. Clin Cancer Res (2010) 1.00
Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer. J Minim Invasive Gynecol (2005) 0.99
Detection of hepatitis E virus shedding in feces of pigs at different stages of production using reverse transcription-polymerase chain reaction. J Vet Diagn Invest (2006) 0.99
Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas. Exp Dermatol (2010) 0.99
A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Res (2004) 0.99
PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. Am J Pathol (2003) 0.99
Metabolic syndrome increases the risk of aggressive prostate cancer detection. BJU Int (2012) 0.99
Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Hum Pathol (2005) 0.98
PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine. Prostate (2010) 0.97
Mouse models of K-ras-initiated carcinogenesis. Biochim Biophys Acta (2005) 0.96
Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum. J Proteome Res (2007) 0.96
Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis (2009) 0.95
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma. Hum Pathol (2010) 0.94
Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells. Neurobiol Aging (2007) 0.94
A three-gene panel on urine increases PSA specificity in the detection of prostate cancer. Prostate (2011) 0.93
Epidemiological and clinical analysis of a consecutive series of conjoined twins in Spain. J Pediatr Surg (2009) 0.93
Change in clinical management of sentinel lymph node location in early stage cervical cancer: the role of SPECT/CT. Gynecol Oncol (2011) 0.93
PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res (2008) 0.93
HPV testing by cobas HPV test in a population from Catalonia. PLoS One (2013) 0.92
Umbilical metastasis after laparoscopic retroperitoneal paraaortic lymphadenectomy for cervical cancer: a true port-site metastasis? Gynecol Oncol (2005) 0.92
Prevalence and genetic characterization of hepatitis E virus in paired samples of feces and serum from naturally infected pigs. Can J Vet Res (2007) 0.92
Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax). Eur J Obstet Gynecol Reprod Biol (2006) 0.92
Autochthonous hepatitis E infection in a slaughterhouse worker. Am J Trop Med Hyg (2007) 0.90
PTOV1 is overexpressed in human high-grade malignant tumors. Virchows Arch (2010) 0.90
An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis. Int J Cancer (2009) 0.90
Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol (2009) 0.90
Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol (2004) 0.90
Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis. Exp Cell Res (2009) 0.90
Electrothermal bipolar vessel sealing system in axillary dissection: a prospective randomized clinical study. Int J Surg (2011) 0.90
Molecular characterization of circulating tumor cells in human metastatic colorectal cancer. PLoS One (2012) 0.89
Acquired retinal astrocytoma managed with endoresection. Retina (2006) 0.89
A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer. Int J Cancer (2014) 0.89
CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma. Histol Histopathol (2011) 0.87
Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells. Gastroenterology (2002) 0.87
Incidence of human papillomavirus infection in male sexual partners of women diagnosed with CIN II-III. Eur J Dermatol (2012) 0.87
Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study. PLoS One (2010) 0.87
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer (2014) 0.87
ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res (2007) 0.86
Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling. Immunity (2005) 0.86